GLW · a US exchange · USD · Market cap $143.0B · 67,200 employees
Corning Incorporated operates in optical communications, display, specialty materials, automotive, and life sciences businesses in the United States, Canada, Mexico, Japan, Taiwan, China, South Korea, Germany, and internationally.
Screened 2026-09-08 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its distribution label.
Corning Inc. holds its Distribution at $165.96. Consolidating, no directional conviction, held for 36 days.
As held on the ledger · 2026-09-08
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 36 days
Price at the screen
$165.96
Valuation
76.13 trailing · 38.19 forward price to earnings
Values screen
PASS· score 83.8
Beta
1.15
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
30.27%
Below 33%
Interest-bearing debt is just 30.3% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
1.65%
Below 33%
Cash held in interest-bearing accounts and securities is 1.7% of assets, under the one-third limit.
Pass
Receivables
13.90%
Below 49%
Money owed to the company is 13.9% of assets, under the 49% limit.
Pass
Revenue purity
0.24%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads OVERVALUED: it trades above our $156.49 fair value estimate, moderate competitive moat, 16.60% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. The price runs 5.7% above the base estimate.
Third-party analyst targets: 15 covering, consensus Strong Buy. The average target sits +21% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Glass Giant's Ethical Edge, But Pricey
Imagine the world without Corning's specialty glass; smartphones, flat screens, and even the Mars Rover would be a lot less advanced. Corning's products are everywhere, and its commitment to ethical practices is just as pervasive, passing our ethical screen with flying colors. Why it stands out is its broad portfolio and moderate competitive moat, backed by a 17% revenue growth and a healthy 11% profit margin.
However, despite its solid performance, the stock is currently priced at a premium, with a Forward P/E of 35.1x, suggesting that investors have already priced in much of the future growth. The market consensus, with a median target of $200, indicates a potential overvaluation, especially considering our fair value estimate of $156.17, which is only 3% higher than the current price.
While Corning's ethical practices and technological prowess are commendable, the risk here is the potential for a cyclical value trap, given the high P/E ratio and the stock's current overvaluation according to our metrics. This is particularly relevant in the technology sector, where earnings can be volatile and subject to rapid changes in market conditions. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
GLW trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-29Markup$151.45+3.3%Entry 12
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 78% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 234%. Our forward projection puts the odds of a 10% gain over the next month near 51%. The street (15 analysts) rates it buy, with a mean price target of $198.
2026-07-28Markup$146.65+0.0%Entry 11
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 78% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 234%. Our forward projection puts the odds of a 10% gain over the next month near 51%. The street (15 analysts) rates it buy, with a mean price target of $198. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-27Markup$146.65+0.0%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 78% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 234%. Our forward projection puts the odds of a 10% gain over the next month near 51%. The street (15 analysts) rates it buy, with a mean price target of $198. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-26Markup$146.65+0.0%Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 78% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 234%. Our forward projection puts the odds of a 10% gain over the next month near 51%. The street (15 analysts) rates it buy, with a mean price target of $198. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-25Markup$146.65-5.1%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 5.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 78% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 234%. Our forward projection puts the odds of a 10% gain over the next month near 51%. The street (15 analysts) rates it buy, with a mean price target of $198. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-24Markup$154.61+0.0%Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 78% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 234%. Our forward projection puts the odds of a 10% gain over the next month near 51%. The street (15 analysts) rates it buy, with a mean price target of $198. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-23Markup$154.61+0.0%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 78% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 234%. Our forward projection puts the odds of a 10% gain over the next month near 51%. The street (15 analysts) rates it buy, with a mean price target of $198. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-22Markup$154.61+0.0%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 78% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 234%. Our forward projection puts the odds of a 10% gain over the next month near 51%. The street (15 analysts) rates it buy, with a mean price target of $198. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-21Markup$154.61-12.9%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 12.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 78% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 234%. Our forward projection puts the odds of a 10% gain over the next month near 51%. The street (15 analysts) rates it buy, with a mean price target of $198. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-18Markup$177.58+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 78% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 234%. Our forward projection puts the odds of a 10% gain over the next month near 51%. The street (15 analysts) rates it buy, with a mean price target of $198.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
